Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer.
about
Redirecting the focus of cancer immunotherapy to premalignant conditions.Human Tumor Antigens Yesterday, Today, and Tomorrow.Overexpression of MUC1 and Genomic Alterations in Its Network Associate with Prostate Cancer Progression.19F-perfluorocarbon-labeled human peripheral blood mononuclear cells can be detected in vivo using clinical MRI parameters in a therapeutic cell setting.Latest developments in MUC1 immunotherapy.Immunogenicity of a Tripartite Cell Penetrating Peptide Containing a MUC1 Variable Number of Tandem Repeat (VNTR) and A T Helper EpitopeConstruction of a set of novel and robust gene expression signatures predicting prostate cancer recurrence
P2860
Q39107022-3FDA1F6F-487C-413F-9635-D711AF9E9A14Q39279256-7D57B763-E084-40FC-90D2-8F1390A4C56CQ41667232-CBE98059-8221-4935-AFFB-B2EC502A971DQ48507624-A4429565-0A81-4CE3-B0A0-6364940687EDQ55417304-78BD2BB5-6542-46F1-956F-FC8496385A69Q58696260-8F58E632-8620-4323-89F8-620EF05288F1Q58788279-B02BA3BE-74DD-4F04-B518-160EE308FD96
P2860
Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Tn-MUC1 DC Vaccination of Rhes ...... ate-Resistant Prostate Cancer.
@en
type
label
Tn-MUC1 DC Vaccination of Rhes ...... ate-Resistant Prostate Cancer.
@en
prefLabel
Tn-MUC1 DC Vaccination of Rhes ...... ate-Resistant Prostate Cancer.
@en
P2093
P2860
P1476
Tn-MUC1 DC Vaccination of Rhes ...... ate-Resistant Prostate Cancer.
@en
P2093
Alain Bergeron
Bader Yassine-Diab
Claire Landry
Corby Fink
David Favre
Elizabeth Scheid
Gregory A Dekaban
Jean Gariepy
Jeffery Gaudet
Louis Lacombe
P2860
P304
P356
10.1158/2326-6066.CIR-15-0189
P577
2016-09-07T00:00:00Z